• Join
  • Login
  • Contact

Search abstracts

Anxiety management non-benzodiazepine drugs; pharmacy compounding lessens the risk of substance abuse and benzodiazepine dependence

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: SER, Filip (City Department for Skin and Veneral Diseases, Belgrade, Serbia)
  • Co-author(s): Draskovic, J. (Pharmacy Belgrade, Belgrade, Serbia)
    Petrovic, B. (Gynecology and Obstetrician University Hospital “Narodni front”, Belgrade, Serbia)
  • Abstract:

    The need to reduce the anxiety is of the utmost importance in everyday dermatologic settings. However benzodiazepine use, despite their proven effectiveness is carrying the potential of habit forming and a difficulty in tapering the dose and terminating the treatment.Adding a low-dose tricycle compound or SSRI is a recommended strategy by clinical


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses